Mainstay Medical
PublicMainstay Medical is now publicly traded
The data on this page reflects Mainstay Medical's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Apr 29, 2014
Last Round
Follow-on Offering
Feb 26, 2024
Total Funding Raised
$436.3M
Company Overview
Mainstay Medical is a medical device company that develops FDA-approved therapies for chronic low back pain, focusing on restoring muscle control and enhancing lumbar spine function to improve patients' quality of life.
Sector
Medical Devices
AI Layer
Non-AI
Keywords
Mainstay Medical Comparables
Compare Mainstay Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cortex, Inc. | 81% | |
| SPR Therapeutics | 72% | |
| Nervonik | 69% |
Mainstay Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Feb 26, 2024 | ||||
| Debt | Sep 9, 2022 | ||||
| Debt | Apr 20, 2021 | ||||
| Follow-on Offering | Feb 16, 2021 | ||||
| Follow-on Offering | Feb 15, 2018 | ||||
Debt | Aug 24, 2015 |
Mainstay Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KCK MedTech | Follow-on Offering |
| IPF Partners | Debt |
| Capricorn Partners | Series B, IPO |
| Perceptive Advisors | Follow-on Offering |
| Ally Bridge Group | Follow-on Offering |
| Fountain Healthcare Partners | Follow-on Offering, IPO, Series B |
| Roebury Nominees One | Series B |
Mainstay Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access